Table S2. Breast Cancer Data pathway analysis results of genes. Ingenuity Pathway Analysis Canonical Pathways from Genes involved in Gene-Metabolite Pairs of the Tumor Correlated Cluster and Tumor Anti-Correlated Cluster. P-values are all calculated from right-tailed Fisherâs Exact Test. (PDF 55Â kb
Sub-pathway distribution of universally upregulated metabolites in all tumor groups. Supplementing F...
Tumor vs Adjacent differentially expressed genes. The full list of 164 significant genes selected fr...
Table S3. Predicted breast cancer driver genes by the seven permutation models. Table S4. Predicted ...
Table S3. Breast Cancer Data pathway analysis results of metabolites. Ingenuity Pathway Analysis Can...
Table S1. NCI-60 Data pathway analysis results of genes. Ingenuity Pathway Analysis Canonical Pathwa...
Figure S2. Preliminary analysis of filtered breast cancer data involving 108 samples (61 tumor and 4...
List of model specific metabolites. Related to Fig. 2. Model specific metabolites were determined b...
PARADIGM analysis in The Cancer Genome Atlas (TCGA). Table S1. Pathways detected by gene set enrichm...
Tumor vs Normal 5 sub-gene signatures. The 5 non-joint 83-gene signatures are included, each consist...
Tumor vs Adjacent 164-gene signature KEGG pathways. Full results of the KEGG human pathway enrichmen...
Raw data for GC/LC-MS/MS metabolomics. Related to Figs. 1 and 2. This table contains all the GC/LC-...
List of 1655 genes with a negative jGRP statistic meaning a down-regulation in LUAD tissues relative...
The Cancer Genome Atlas (TCGA) Ingenuity pathway analysis (IPA) upstream regulators. Table S1., Tabl...
Tumor vs Normal 415-gene signature KEGG pathways. Full results of the KEGG human pathway enrichment ...
Data S1. NCI-60 Results with FDR Adjusted p-value < 0.10 and Correlation Difference > 0.50. (XLSX 10...
Sub-pathway distribution of universally upregulated metabolites in all tumor groups. Supplementing F...
Tumor vs Adjacent differentially expressed genes. The full list of 164 significant genes selected fr...
Table S3. Predicted breast cancer driver genes by the seven permutation models. Table S4. Predicted ...
Table S3. Breast Cancer Data pathway analysis results of metabolites. Ingenuity Pathway Analysis Can...
Table S1. NCI-60 Data pathway analysis results of genes. Ingenuity Pathway Analysis Canonical Pathwa...
Figure S2. Preliminary analysis of filtered breast cancer data involving 108 samples (61 tumor and 4...
List of model specific metabolites. Related to Fig. 2. Model specific metabolites were determined b...
PARADIGM analysis in The Cancer Genome Atlas (TCGA). Table S1. Pathways detected by gene set enrichm...
Tumor vs Normal 5 sub-gene signatures. The 5 non-joint 83-gene signatures are included, each consist...
Tumor vs Adjacent 164-gene signature KEGG pathways. Full results of the KEGG human pathway enrichmen...
Raw data for GC/LC-MS/MS metabolomics. Related to Figs. 1 and 2. This table contains all the GC/LC-...
List of 1655 genes with a negative jGRP statistic meaning a down-regulation in LUAD tissues relative...
The Cancer Genome Atlas (TCGA) Ingenuity pathway analysis (IPA) upstream regulators. Table S1., Tabl...
Tumor vs Normal 415-gene signature KEGG pathways. Full results of the KEGG human pathway enrichment ...
Data S1. NCI-60 Results with FDR Adjusted p-value < 0.10 and Correlation Difference > 0.50. (XLSX 10...
Sub-pathway distribution of universally upregulated metabolites in all tumor groups. Supplementing F...
Tumor vs Adjacent differentially expressed genes. The full list of 164 significant genes selected fr...
Table S3. Predicted breast cancer driver genes by the seven permutation models. Table S4. Predicted ...